Rockwell Medical Announces Dosing of First Patient in Pivotal Triferic® Phase 3 Trial by Partner, Wanbang Biopharmaceuticals, in China
January 13, 2021 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Jan. 13, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI), a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and iron deficiency...
Rockwell Medical, Inc. to Present at H.C. Wainwright BioConnect 2021 Conference
January 05, 2021 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Jan. 05, 2021 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Industry Veteran Andrea Heslin Smiley joins Rockwell Medical’s Board of Directors
December 16, 2020 07:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Dec. 16, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical, Inc. Provides Third Quarter 2020 Financial and Operational Update
November 09, 2020 16:05 ET
|
Rockwell Medical, Inc.
-Ended the quarter with $67.3 million in cash, cash equivalents and investments- -Q3 2020 revenue of $15.3 million- -U.S. commercial launch of Triferic® AVNU expected in Q1 2021- -Poised to enroll...
Rockwell Medical to Report Third Quarter 2020 Financial and Operating Results on November 9, 2020
October 27, 2020 08:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Oct. 27, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) ("Rockwell Medical" or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical, Inc. Announces Presentations at the American Society of Nephrology Virtual Kidney Week 2020
October 13, 2020 08:00 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Oct. 13, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical Announces Growth Plan and New Therapeutic Opportunities for Its Ferric Pyrophosphate Citrate (FPC) Platform
September 24, 2020 18:09 ET
|
Rockwell Medical, Inc.
-New indications for FPC platform provide significant growth opportunity- -Anticipates Type C meeting with FDA for home infusion in Q1 2021 and for acute heart failure in 2H 2021- ...
Rockwell Medical Announces $35.0 Million Registered Direct Offering Priced At-The-Market under Nasdaq Rules
September 23, 2020 08:45 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 23, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical Announces Appointment of Russell L. Skibsted as Executive Vice President, Chief Financial Officer and Chief Business Officer
September 15, 2020 07:59 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 15, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...
Rockwell Medical Enters into Exclusive License Agreement with Jeil Pharmaceutical Co., Ltd., for the Rights to Commercialize Triferic® in South Korea
September 09, 2020 16:15 ET
|
Rockwell Medical, Inc.
WIXOM, Mich., Sept. 09, 2020 (GLOBE NEWSWIRE) -- Rockwell Medical, Inc. (Nasdaq: RMTI) (“Rockwell Medical” or the “Company”), a biopharmaceutical company dedicated to transforming the treatment of...